Viral vector production for cell and gene therapy relies on successful transfection, but traditional transfection techniques do not favor production scale up. Transfection reagents that facilitate large scale virus production enable scientists to generate high viral titers to meet clinical application demands.
Download this white paper from Mirus to learn how to optimize transfection and generate high titer viral vectors for cell and gene therapies.